Drug information for MYOZYME
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; IV (INFUSION)
20MG/KG
Prescription
ALGLUCOSIDASE ALFA
GAA protein, human
GENZYME
125141
2009-01-16 Label
2008-12-24 Letter
2006-06-21 Review
2006-05-02 Letter
2006-04-28 Label
Drug Adverse Effects information for MYOZYME
Role code
Indications
Reaction
# Reports
PS
ANAEMIA
COLON CANCER METASTATIC
1
PS
COLITIS ULCERATIVE
CONVULSION
4
PS
COLITIS ULCERATIVE
SUBDURAL HAEMATOMA
4
PS
DROOLING
RESPIRATORY FAILURE
1
PS
DROOLING
STAPHYLOCOCCAL SEPSIS
1
PS
DROOLING
THERAPEUTIC RESPONSE DECREASED
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
ADRENAL GLAND CANCER METASTATIC
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
AORTIC DISSECTION
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
ARRHYTHMIA
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
ASTHENIA
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
BREAST CANCER METASTATIC
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
CANDIDIASIS
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
CARDIAC ARREST
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
CARDIAC FAILURE
7
PS
GLYCOGEN STORAGE DISEASE TYPE II
CARDIO-RESPIRATORY ARREST
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
CARDIOPULMONARY FAILURE
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
CARDIOVASCULAR DISORDER
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
COLON CANCER METASTATIC
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
CONVULSION
5
PS
GLYCOGEN STORAGE DISEASE TYPE II
DEATH
10
PS
GLYCOGEN STORAGE DISEASE TYPE II
DECUBITUS ULCER
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
DISEASE PROGRESSION
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
DRUG HYPERSENSITIVITY
4
PS
GLYCOGEN STORAGE DISEASE TYPE II
DYSPNOEA
2
PS
GLYCOGEN STORAGE DISEASE TYPE II
ERYTHEMA
4
PS
GLYCOGEN STORAGE DISEASE TYPE II
FLUSHING
4
PS
GLYCOGEN STORAGE DISEASE TYPE II
FOETAL HEART RATE DECELERATION
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
GASTROINTESTINAL HAEMORRHAGE
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
HYPERSENSITIVITY
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
HYPOTHERMIA
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
IRRITABILITY
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
LOW BIRTH WEIGHT BABY
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
MOTOR DYSFUNCTION
2
PS
GLYCOGEN STORAGE DISEASE TYPE II
MUSCULAR WEAKNESS
2
PS
GLYCOGEN STORAGE DISEASE TYPE II
MYOCARDIAL INFARCTION
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
PLACENTAL DISORDER
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
PNEUMONIA ASPIRATION
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
PNEUMOTHORAX
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
PREMATURE BABY
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
PREMATURE RUPTURE OF MEMBRANES
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
PSEUDOMONAS INFECTION
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
PULMONARY HYPERTENSION
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
PYREXIA
2
PS
GLYCOGEN STORAGE DISEASE TYPE II
RESPIRATORY DISORDER
3
PS
GLYCOGEN STORAGE DISEASE TYPE II
RESPIRATORY DISTRESS
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
RESPIRATORY FAILURE
4
PS
GLYCOGEN STORAGE DISEASE TYPE II
SEPSIS
2
PS
GLYCOGEN STORAGE DISEASE TYPE II
SKIN NECROSIS
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
STAPHYLOCOCCAL SEPSIS
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
SUBDURAL HAEMATOMA
4
PS
GLYCOGEN STORAGE DISEASE TYPE II
SUDDEN DEATH
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
THERAPEUTIC RESPONSE DECREASED
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
UPPER RESPIRATORY TRACT INFECTION
1
PS
GLYCOGEN STORAGE DISEASE TYPE II
URINARY TRACT INFECTION
1
PS
HYPERTENSION
COLON CANCER METASTATIC
1
PS
IMMUNOSUPPRESSION
DYSPNOEA
1
PS
IMMUNOSUPPRESSION
PNEUMOTHORAX
1
PS
IMMUNOSUPPRESSION
PYREXIA
1
PS
INFECTION
DYSPNOEA
1
PS
INFECTION
PNEUMOTHORAX
1
PS
INFECTION
PYREXIA
1
PS
NAUSEA
COLON CANCER METASTATIC
1
PS
OSTEOPOROSIS
COLON CANCER METASTATIC
1
PS
PREMEDICATION
CONVULSION
2
PS
PREMEDICATION
GASTROINTESTINAL HAEMORRHAGE
2
PS
PREMEDICATION
IRRITABILITY
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
CARDIAC FAILURE
5
PS
PRODUCT USED FOR UNKNOWN INDICATION
CARDIOPULMONARY FAILURE
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
CARDIOVASCULAR DISORDER
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
COLON CANCER METASTATIC
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
CONVULSION
23
PS
PRODUCT USED FOR UNKNOWN INDICATION
DISEASE PROGRESSION
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
GASTROINTESTINAL HAEMORRHAGE
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
IRRITABILITY
9
PS
PRODUCT USED FOR UNKNOWN INDICATION
PULMONARY HYPERTENSION
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
SUBDURAL HAEMATOMA
14
SS
COLITIS ULCERATIVE
CONVULSION
16
SS
COLITIS ULCERATIVE
SUBDURAL HAEMATOMA
16
SS
DROOLING
RESPIRATORY FAILURE
1
SS
DROOLING
STAPHYLOCOCCAL SEPSIS
1
SS
DROOLING
THERAPEUTIC RESPONSE DECREASED
1
SS
GLYCOGEN STORAGE DISEASE TYPE II
CONVULSION
16
SS
GLYCOGEN STORAGE DISEASE TYPE II
RESPIRATORY FAILURE
1
SS
GLYCOGEN STORAGE DISEASE TYPE II
STAPHYLOCOCCAL SEPSIS
1
SS
GLYCOGEN STORAGE DISEASE TYPE II
SUBDURAL HAEMATOMA
16
SS
GLYCOGEN STORAGE DISEASE TYPE II
THERAPEUTIC RESPONSE DECREASED
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
CONVULSION
56
SS
PRODUCT USED FOR UNKNOWN INDICATION
SUBDURAL HAEMATOMA
56
C
GLYCOGEN STORAGE DISEASE TYPE II
ALANINE AMINOTRANSFERASE INCREASED
1
C
GLYCOGEN STORAGE DISEASE TYPE II
ASPARTATE AMINOTRANSFERASE INCREASED
1
C
GLYCOGEN STORAGE DISEASE TYPE II
CHEST X-RAY ABNORMAL
1
C
GLYCOGEN STORAGE DISEASE TYPE II
HEADACHE
1
C
GLYCOGEN STORAGE DISEASE TYPE II
PNEUMONIA
1
C
GLYCOGEN STORAGE DISEASE TYPE II
PYREXIA
1
C
GLYCOGEN STORAGE DISEASE TYPE II
RED BLOOD CELL SEDIMENTATION RATE INCREASED
1
Ads by Google